Reckitt Benckiser Group stock (GB00B24CGK77): ADRs hit 52-week low amid buyback

Reckitt Benckiser Group's ADRs touched a new 52-week low near $12.60 on OTCQX, as the London-listed firm continues its share repurchase program with a recent buy of 190,000 shares on May 8, 2026.

Reckitt Benckiser Group plc's American Depositary Receipts (OTCMKTS: RBGLY) recently hit a new 52-week low around $12.52, last trading near $12.61 on modest volume, ad-hoc-news as of early May 2026. Meanwhile, the company executed a share buyback of 190,000 ordinary shares on May 8, 2026, from Deutsche Bank, TipRanks as of May 2026. Analysts hold a moderate-buy consensus despite the price pressure.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Reckitt Benckiser Group plc
• Sector/industry: Consumer goods (hygiene, health, nutrition)
• Headquarters/country: United Kingdom
• Core markets: Global, with strong US presence
• Key revenue drivers: Consumer health, hygiene, nutrition products
• Home exchange/listing venue: London Stock Exchange (RKT)
• Trading currency: GBP (primary); USD for ADRs

Reckitt Benckiser Group: core business model

Reckitt Benckiser Group plc manufactures and markets health, hygiene, and nutrition products worldwide. Its portfolio includes well-known brands such as Lysol, Dettol, Nurofen, Gaviscon, and Mead Johnson infant nutrition. The company operates through three main segments: Hygiene, Health, and Nutrition, serving consumers in over 60 countries with a focus on everyday essential products. Reckitt emphasizes innovation in product formulations to meet evolving consumer needs in cleaning, personal care, and over-the-counter remedies.

Main revenue and product drivers for Reckitt Benckiser Group

Revenue is primarily driven by Hygiene (disinfectants, surface care), Health (pain relief, digestive health), and Nutrition (infant formula, specialized nutrition). In recent quarters, like-for-like sales growth has been supported by pricing and volume in powerbrands, though Nutrition faced headwinds from supply issues. The US market represents a key growth area, with strong demand for hygiene products post-pandemic, contributing significantly to overall sales as per company reports.

Industry trends and competitive position

The consumer goods sector faces inflation pressures, supply chain challenges, and shifting consumer preferences toward sustainable products. Reckitt holds a strong position with leading market shares in hygiene and health categories, competing with Procter & Gamble, Unilever, and Colgate-Palmolive. Its focus on premium powerbrands and e-commerce expansion bolsters resilience, particularly in the US where hygiene awareness remains elevated.

Why Reckitt Benckiser Group matters for US investors

US investors can access Reckitt via OTCQX-traded ADRs (RBGLY), offering exposure to a defensive consumer staples giant with substantial North American revenue from brands like Lysol and Enfamil. The firm's global diversification tempers regional risks, while its London listing provides currency play opportunities amid GBP/USD fluctuations relevant to US portfolios.

Conclusion

Reckitt Benckiser Group continues its share buyback amid ADR prices near 52-week lows, reflecting valuation pressures despite a stable consumer essentials business. Ongoing repurchases signal management confidence, while analyst moderate-buy views suggest potential upside. US investors should monitor upcoming results for growth in key US-exposed segments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.